Valsartan MDL Judge OKs Out-Of-State Litigants, More Claims

By Jeannie O'Sullivan · April 5, 2022, 7:53 PM EDT

A New Jersey federal judge ruled Tuesday that multidistrict litigation against drug manufacturers, pharmacies and wholesalers over carcinogens in blood pressure drugs can expand to include out-of-state litigants and warranty claims...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Decision

Case Information

Case Title

VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION

Case Number

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

February 14, 2019

Recent Articles By Jeannie

December 13, 2023
Pa. Justices Will Review Order Allowing Hospital Closure
April 13, 2022
Nursing Home Workers' Insurance Scam Claims Survive
April 06, 2022
Titan Of The Plaintiffs Bar: Joseph Saveri's Steven Williams
March 31, 2022
Health Plans Squeezed By Opioid Drug Scheme, 3rd Circ. Told
March 16, 2022
Virus Whistleblower Suit Short On Specifics, NJ Officials Say
March 10, 2022
NJ Court Must Rethink Archer DQ In Dental Office Biz Dispute
March 04, 2022
Fact Disputes Keep Cardiac Hospital's ER Contract Row Alive
February 28, 2022
3rd Circ. Preview: March Roars With Ch. 11, Poaching Spats
February 22, 2022
Charities Ensnared In NJ Antitrust Suit Over Cancer Drugs
February 18, 2022
NJ Health System Aims To Toss Breach Suit Over ER Contract